Medical News

RSS

More people show interest in getting their DNA tested, finds new poll

Only a small percentage of people in their 50s and early 60s have had their DNA tested - either for medical reasons, to learn their ancestry or out of curiosity - but far more have an interest in getting such tests done, according to a new poll.

1 Oct 2018

Why patients with ALL relapse after CAR-T cell therapy

Researchers have made a new discovery about a rare mechanism that triggers the relapse of acute lymphoblastic leukemia (ALL) after CAR T cell therapy.

1 Oct 2018

Why patients with ALL relapse after CAR-T cell therapy

Researchers have made a new discovery about a rare mechanism that triggers the relapse of acute lymphoblastic leukemia (ALL) after CAR T cell therapy.

1 Oct 2018

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited announced today that the phase 3 ECHELON-2 clinical trial met its primary endpoint.

1 Oct 2018

Many Alzheimer's patients are taking two or more psychotropic drugs

Up to 50% of people with Alzheimer’s disease now take a psychotropic drug and one-fifth use a combination of two or more psychotropic drugs.

1 Oct 2018

TransEnterix’s Senhance Ultrasonic Instrument System receives CE Mark approval

TransEnterix, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that the Company received CE Mark approval for its Senhance Ultrasonic Instrument System.

1 Oct 2018

HyFly research project aims to break chains of infection and prevent pandemics

Global air travel isn't restricted to people and goods - infectious agents, too, can make their way on board as unwelcome passengers and travel great distances within a matter of hours.

1 Oct 2018

Gangrene-causing bacteria show promise as cancer treatment

Researchers have found that the bacteria responsible for causing gangrene could also be used to treat patients with certain cancers.

1 Oct 2018

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma 2009 trial.

1 Oct 2018

Child sleep disorders on the rise due to social media and obesity

More and more children in England are being diagnosed with sleep problems, including nightmares, sleepwalking, and insomnia.

1 Oct 2018

Aspirin shown to prevent the spread of cancer

New research by Cardiff University has demonstrated a role for Aspirin in the treatment of bowel, prostate and breast cancer.

1 Oct 2018

Researchers identify genes that could help predict treatment outcomes for parasitic disease

Researchers at the University of York have identified genes in a parasite that could help clinicians predict drug treatment outcomes for patients with visceral leishmaniasis in Brazil.

1 Oct 2018

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

Up to half of people with Alzheimer's disease use a psychotropic drug, and one in five uses two or more psychotropics concomitantly, according to a study conducted at the University of Eastern Finland.

1 Oct 2018

MTF Biologics introduces Flexhd Pliable PRE for pre-pectoral breast reconstruction

MTF Biologics is expanding its portfolio of innovations for post-mastectomy breast reconstruction with the launch of an acellular dermal matrix designed specifically for pre-pectoral breast reconstruction procedures: FlexHD Pliable PRE.

1 Oct 2018

Xenex LightStrike Germ-Zapping Robots help reduce infection rates at Martin Medical Center

Patient safety is a top priority at Martin Medical Center, which recently announced that it has seen a significant reduction in its Clostridium difficile (C.diff) infection rates since adopting Xenex LightStrike Germ-Zapping Robots as its environmental standard of care.

1 Oct 2018

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

Masimo announced today the findings of an abstract presented at the 2018 Congress of the French Society of Anesthesia and Resuscitation in Paris in which researchers at CHU Angers in France investigated the ability of Masimo ORi™ to help clinicians reduce the number of days ICU patients experience hyperoxemia while on mechanical ventilation.

1 Oct 2018

International conference features cutting-edge research studies on cancer immunotherapy

The Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, to be held in New York, Sept. 30-Oct. 3, will feature cutting-edge research studies from around the world that endeavor to answer urgent questions in the field of cancer immunotherapy to advance progress more rapidly for patients.

1 Oct 2018

Chiropractic treatment could lead to vision problems

For those in the habit of getting their neck adjusted by a chiropractor, the University of Michigan Kellogg Eye Center has interesting information to know about: High velocity neck manipulation has been shown to result in stress on the eye and lead to spotty vision.

1 Oct 2018

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.

1 Oct 2018

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

The health care systems in some European countries lack the capacity to rapidly move a disease-modifying treatment for Alzheimer's disease from approval into widespread clinical use, which could leave 1 million people without access to transformative care if such a breakthrough occurs, according to a new RAND Corporation study.

1 Oct 2018

Medical News

More people show interest in getting their DNA tested, finds new poll

Why patients with ALL relapse after CAR-T cell therapy

Why patients with ALL relapse after CAR-T cell therapy

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Many Alzheimer's patients are taking two or more psychotropic drugs

TransEnterix’s Senhance Ultrasonic Instrument System receives CE Mark approval

HyFly research project aims to break chains of infection and prevent pandemics

Gangrene-causing bacteria show promise as cancer treatment

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Child sleep disorders on the rise due to social media and obesity

Aspirin shown to prevent the spread of cancer

Researchers identify genes that could help predict treatment outcomes for parasitic disease

Up to half of people with Alzheimer's disease use psychotropic drug, finds study

MTF Biologics introduces Flexhd Pliable PRE for pre-pectoral breast reconstruction

Xenex LightStrike Germ-Zapping Robots help reduce infection rates at Martin Medical Center

Researchers investigate ability of Masimo ORi to reduce time ICU patients experience hyperoxemia

International conference features cutting-edge research studies on cancer immunotherapy

Chiropractic treatment could lead to vision problems

Eisai's antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients

EU countries lack capacity to rapidly move future Alzheimer's treatment into clinical use

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News